For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Dexmedetomidine (Sedative (selective α2-agonist)) – indications: Sedation of ICU patients (adults, target RASS 0 to −3), Sedation of non-intubated adults for procedures (incl. awake fibreoptic intubation). Weight-based dosing in mg and ml in the app, with sources.
Indications
- Sedation of ICU patients (adults, target RASS 0 to −3)
- Sedation of non-intubated adults for procedures (incl. awake fibreoptic intubation)
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Used in
Sources and guidelines
- Summaries of product characteristics of authorised products – product and section for each dose in the app.